{"id":42940,"date":"2025-10-09T15:20:53","date_gmt":"2025-10-09T07:20:53","guid":{"rendered":"https:\/\/flcube.com\/?p=42940"},"modified":"2025-10-09T15:20:54","modified_gmt":"2025-10-09T07:20:54","slug":"walvax-biotech-wins-jordan-fda-approval-for-13%e2%80%91valent-pneumococcal-vaccine","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=42940","title":{"rendered":"Walvax Biotech Wins Jordan FDA Approval for 13\u2011Valent Pneumococcal Vaccine"},"content":{"rendered":"\n<p>China\u2011based Walvax Biotechnology Co., Ltd. (<a href=\"https:\/\/www.google.com\/finance\/quote\/300142:SHE\">SHE: 300142<\/a>) has secured market approval from the Jordan Food &amp; Drug Administration for its 13\u2011valent pneumococcal polysaccharide conjugate vaccine (PCV\u201113). The decision expands the company\u2019s footprint in the Middle East and reinforces its position as a leading developer of pediatric immunizations.<\/p>\n\n\n\n<p><strong>Product Profile<\/strong><br>Walvax\u2019s PCV\u201113 protects infants and young children aged 6\u202fweeks to 5\u202fyears against 13 invasive pneumococcal serotypes: 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F. The vaccine, first approved in China in 2020, has demonstrated robust immunogenicity and a favorable safety profile in clinical studies, making it a key tool in reducing childhood pneumonia and invasive disease burden.<\/p>\n\n\n\n<p><strong>Regulatory Milestone and Market Outlook<\/strong><br>The Jordan FDA\u2019s approval marks a significant regulatory milestone that could open access to a sizable market of over 8\u202fmillion children. With local distribution agreements in place, Walvax plans to roll out the vaccine within the next 12\u202fmonths, targeting both public health programs and private pediatric practices.<\/p>\n\n\n\n<p><strong>Conclusion<\/strong><br>Walvax\u2019s entry into the Jordanian market underscores the growing global demand for high\u2011valency pneumococcal vaccines. By extending its reach beyond China, the company positions itself to capture a share of the expanding pediatric vaccine market in the region.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/\u6c83\u68ee\u751f\u7269\uff1a\u5173\u4e8e\u5b50\u516c\u53f8\u6536\u523013\u4ef7\u80ba\u708e\u7403\u83cc\u591a\u7cd6\u7ed3\u5408\u75ab\u82d7\u7ea6\u65e6\u836f\u54c1\u6ce8\u518c\u8bc1\u7684\u516c\u544a.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of \u6c83\u68ee\u751f\u7269\uff1a\u5173\u4e8e\u5b50\u516c\u53f8\u6536\u523013\u4ef7\u80ba\u708e\u7403\u83cc\u591a\u7cd6\u7ed3\u5408\u75ab\u82d7\u7ea6\u65e6\u836f\u54c1\u6ce8\u518c\u8bc1\u7684\u516c\u544a.\"><\/object><a id=\"wp-block-file--media-804a85c2-9b3f-490d-887d-d0b8aafcc2e4\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/\u6c83\u68ee\u751f\u7269\uff1a\u5173\u4e8e\u5b50\u516c\u53f8\u6536\u523013\u4ef7\u80ba\u708e\u7403\u83cc\u591a\u7cd6\u7ed3\u5408\u75ab\u82d7\u7ea6\u65e6\u836f\u54c1\u6ce8\u518c\u8bc1\u7684\u516c\u544a.pdf\">\u6c83\u68ee\u751f\u7269\uff1a\u5173\u4e8e\u5b50\u516c\u53f8\u6536\u523013\u4ef7\u80ba\u708e\u7403\u83cc\u591a\u7cd6\u7ed3\u5408\u75ab\u82d7\u7ea6\u65e6\u836f\u54c1\u6ce8\u518c\u8bc1\u7684\u516c\u544a<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/\u6c83\u68ee\u751f\u7269\uff1a\u5173\u4e8e\u5b50\u516c\u53f8\u6536\u523013\u4ef7\u80ba\u708e\u7403\u83cc\u591a\u7cd6\u7ed3\u5408\u75ab\u82d7\u7ea6\u65e6\u836f\u54c1\u6ce8\u518c\u8bc1\u7684\u516c\u544a.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-804a85c2-9b3f-490d-887d-d0b8aafcc2e4\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>China\u2011based Walvax Biotechnology Co., Ltd. (SHE: 300142) has secured market approval from the Jordan Food&#8230;<\/p>\n","protected":false},"author":1,"featured_media":42942,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,11],"tags":[15,1152,12,332],"class_list":["post-42940","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-drug","tag-product-approvals","tag-she-300142","tag-vaccine","tag-walvax-biotechnology"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Walvax Biotech Wins Jordan FDA Approval for 13\u2011Valent Pneumococcal Vaccine - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China\u2011based Walvax Biotechnology Co., Ltd. (SHE: 300142) has secured market approval from the Jordan Food &amp; Drug Administration for its 13\u2011valent pneumococcal polysaccharide conjugate vaccine (PCV\u201113). The decision expands the company\u2019s footprint in the Middle East and reinforces its position as a leading developer of pediatric immunizations.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=42940\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Walvax Biotech Wins Jordan FDA Approval for 13\u2011Valent Pneumococcal Vaccine\" \/>\n<meta property=\"og:description\" content=\"China\u2011based Walvax Biotechnology Co., Ltd. (SHE: 300142) has secured market approval from the Jordan Food &amp; Drug Administration for its 13\u2011valent pneumococcal polysaccharide conjugate vaccine (PCV\u201113). The decision expands the company\u2019s footprint in the Middle East and reinforces its position as a leading developer of pediatric immunizations.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=42940\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-09T07:20:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-09T07:20:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/0905.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42940#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42940\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Walvax Biotech Wins Jordan FDA Approval for 13\u2011Valent Pneumococcal Vaccine\",\"datePublished\":\"2025-10-09T07:20:53+00:00\",\"dateModified\":\"2025-10-09T07:20:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42940\"},\"wordCount\":216,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42940#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/0905.webp\",\"keywords\":[\"Product approvals\",\"SHE: 300142\",\"Vaccine\",\"Walvax Biotechnology\"],\"articleSection\":[\"Company\",\"Drug\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=42940#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42940\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=42940\",\"name\":\"Walvax Biotech Wins Jordan FDA Approval for 13\u2011Valent Pneumococcal Vaccine - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42940#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42940#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/0905.webp\",\"datePublished\":\"2025-10-09T07:20:53+00:00\",\"dateModified\":\"2025-10-09T07:20:54+00:00\",\"description\":\"China\u2011based Walvax Biotechnology Co., Ltd. (SHE: 300142) has secured market approval from the Jordan Food & Drug Administration for its 13\u2011valent pneumococcal polysaccharide conjugate vaccine (PCV\u201113). The decision expands the company\u2019s footprint in the Middle East and reinforces its position as a leading developer of pediatric immunizations.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42940#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=42940\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42940#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/0905.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/0905.webp\",\"width\":1080,\"height\":608,\"caption\":\"Walvax Biotech Wins Jordan FDA Approval for 13\u2011Valent Pneumococcal Vaccine\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42940#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Walvax Biotech Wins Jordan FDA Approval for 13\u2011Valent Pneumococcal Vaccine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Walvax Biotech Wins Jordan FDA Approval for 13\u2011Valent Pneumococcal Vaccine - Insight, China&#039;s Pharmaceutical Industry","description":"China\u2011based Walvax Biotechnology Co., Ltd. (SHE: 300142) has secured market approval from the Jordan Food & Drug Administration for its 13\u2011valent pneumococcal polysaccharide conjugate vaccine (PCV\u201113). The decision expands the company\u2019s footprint in the Middle East and reinforces its position as a leading developer of pediatric immunizations.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=42940","og_locale":"en_US","og_type":"article","og_title":"Walvax Biotech Wins Jordan FDA Approval for 13\u2011Valent Pneumococcal Vaccine","og_description":"China\u2011based Walvax Biotechnology Co., Ltd. (SHE: 300142) has secured market approval from the Jordan Food & Drug Administration for its 13\u2011valent pneumococcal polysaccharide conjugate vaccine (PCV\u201113). The decision expands the company\u2019s footprint in the Middle East and reinforces its position as a leading developer of pediatric immunizations.","og_url":"https:\/\/flcube.com\/?p=42940","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-10-09T07:20:53+00:00","article_modified_time":"2025-10-09T07:20:54+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/0905.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=42940#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=42940"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Walvax Biotech Wins Jordan FDA Approval for 13\u2011Valent Pneumococcal Vaccine","datePublished":"2025-10-09T07:20:53+00:00","dateModified":"2025-10-09T07:20:54+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=42940"},"wordCount":216,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=42940#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/0905.webp","keywords":["Product approvals","SHE: 300142","Vaccine","Walvax Biotechnology"],"articleSection":["Company","Drug"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=42940#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=42940","url":"https:\/\/flcube.com\/?p=42940","name":"Walvax Biotech Wins Jordan FDA Approval for 13\u2011Valent Pneumococcal Vaccine - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=42940#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=42940#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/0905.webp","datePublished":"2025-10-09T07:20:53+00:00","dateModified":"2025-10-09T07:20:54+00:00","description":"China\u2011based Walvax Biotechnology Co., Ltd. (SHE: 300142) has secured market approval from the Jordan Food & Drug Administration for its 13\u2011valent pneumococcal polysaccharide conjugate vaccine (PCV\u201113). The decision expands the company\u2019s footprint in the Middle East and reinforces its position as a leading developer of pediatric immunizations.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=42940#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=42940"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=42940#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/0905.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/0905.webp","width":1080,"height":608,"caption":"Walvax Biotech Wins Jordan FDA Approval for 13\u2011Valent Pneumococcal Vaccine"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=42940#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Walvax Biotech Wins Jordan FDA Approval for 13\u2011Valent Pneumococcal Vaccine"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/10\/0905.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/42940","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=42940"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/42940\/revisions"}],"predecessor-version":[{"id":42943,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/42940\/revisions\/42943"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/42942"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=42940"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=42940"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=42940"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}